Resting Energy Expenditure in Patients With Familial Dysautonomia: A Preliminary Study.


Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 20 10 2018
medline: 26 3 2020
entrez: 19 10 2018
Statut: ppublish

Résumé

Familial dysautonomia (FD) is a rare hereditary sensory and autonomic neuropathy characterized by chronic lung disease and cyclic vomiting due to hyper-adrenergic crises. Most FD patients are in a depleted nutritional state; however, the phenotype of the disease is quite different between patients, as for the severity of lung disease and the intensity and frequency of these pathognomonic crises. In this study we wanted to investigate whether resting energy expenditure (REE) levels are increased in this population, and if correlations exist between REE levels and phenotype severity. Data was collected from 12 FD patients (6/6 m/f). REE measurements were conducted by indirect calorimeter. Measured REE % predicted were correlated with pulmonary function, severity of the scoliosis, serum C-reactive protein, yearly frequency of hyperadrenergic crisis, hospital admissions and the use of nocturnal noninvasive positive pressure ventilation. Mean REE was 112 ±13% predicted with 50% being in a hypermetabolic state (REE/HB > 110%). Body mass index (BMI) was below normal range in 75% of patients, and reduced energy intake was also decreased in 75%. No significant correlations to disease severity factors were found. When dividing the subjects to REE levels above or below 125% predicted, Patients with REE above 125% predicted presented with significantly lower inspiratory capacity (42.7% predicted vs 62.8% predicted; P = 0.04). Hypermetabolic state was described in 50% of FD patients. The Low BMI is explained by combination of relative anorexia and increased REE. The REE levels are related to the underling respiratory disease.

Identifiants

pubmed: 30334929
doi: 10.1097/MPG.0000000000002180
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-427

Subventions

Organisme : NINDS NIH HHS
ID : U54 NS065736
Pays : United States

Auteurs

Bat-El Bar Aluma (BE)

Pulmonary Unit and the National Center for Cystic Fibrosis and Dysautonomia Center.

Lucy Norcliffe-Kaufmann (L)

Dysautonomia Center, New York University School of Medicine, New York, NY.

Ifat Sarouk (I)

Pulmonary Unit and the National Center for Cystic Fibrosis and Dysautonomia Center.

Adi Dagan (A)

Pulmonary Unit and the National Center for Cystic Fibrosis and Dysautonomia Center.

Moshe Ashkenazi (M)

Pulmonary Unit and the National Center for Cystic Fibrosis and Dysautonomia Center.

Daphna Vilozni (D)

Pulmonary Unit and the National Center for Cystic Fibrosis and Dysautonomia Center.

Avishay Lahad (A)

Pediatric Gastroenterlogy Unit, Edmond and Lily Safra Children's Pediatric Hospital, Sheba Medical Center, Affiliated to the Sackler Medical School, Tel Aviv University, Tel Hashomer, Israel.

Ori Efrati (O)

Pulmonary Unit and the National Center for Cystic Fibrosis and Dysautonomia Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH